We are an independent start-up based in Ticino. We focus on generation, development and characterization of nanobodies produced from proprietary, rationally engineered human libraries relevant to enhance the R&D pipeline of partners and clients.
What are the core strengths of your current team and what skills are you looking forward to integrate in the future?
CLB was founded by scientists trained at Cambridge and Stanford with publications on the most prestigious scientific journals. Our Mission is pre-clinical R&D through antibody discovery, development and engineering, expanding the R&D pipelines of partnering Pharma Companies with nanobodies libraries